Annual CFF
$142.01 M
+$101.27 M+248.63%
December 31, 2023
Summary
- As of February 10, 2025, FUSN annual cash flow from financing activities is $142.01 million, with the most recent change of +$101.27 million (+248.63%) on December 31, 2023.
- During the last 3 years, FUSN annual CFF has fallen by -$123.50 million (-46.52%).
Performance
FUSN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$64.01 M
+$6.16 M+10.64%
March 31, 2024
Summary
- As of February 10, 2025, FUSN quarterly cash flow from financing activities is $64.01 million, with the most recent change of +$6.16 million (+10.64%) on March 31, 2024.
- Over the past year, FUSN quarterly CFF has increased by +$63.68 million (+19415.55%).
Performance
FUSN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$146.50 M
+$4.50 M+3.17%
March 31, 2024
Summary
- As of February 10, 2025, FUSN TTM cash flow from financing activities is $146.50 million, with the most recent change of +$4.50 million (+3.17%) on March 31, 2024.
- Over the past year, FUSN TTM CFF has increased by +$62.22 million (+73.82%).
Performance
FUSN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FUSN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +248.6% | +10000.0% | +73.8% |
| 3 y3 years | -46.5% | +10000.0% | +73.8% |
| 5 y5 years | +673.1% | +10000.0% | +73.8% |
FUSN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -99.8% | at high | -100.1% | at high | -99.8% |
| 5 y | 5-year | -46.5% | -99.8% | -75.2% | -103.6% | -45.3% | -101.3% |
| alltime | all time | -46.5% | -99.8% | -75.2% | -103.6% | -45.3% | -101.3% |
Fusion Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $64.01 M(+10.6%) | $146.50 M(+3.2%) |
| Dec 2023 | $142.01 M(+248.6%) | $57.85 M(>+9900.0%) | $142.01 M(+68.5%) |
| Sep 2023 | - | $328.00 K(-98.7%) | $84.28 M(-25.3%) |
| Jun 2023 | - | $24.31 M(-59.2%) | $112.86 M(+14.5%) |
| Mar 2023 | - | $59.52 M(>+9900.0%) | $98.54 M(+141.9%) |
| Dec 2022 | $40.73 M(>+9900.0%) | $131.00 K(-99.5%) | $40.73 M(+0.4%) |
| Sep 2022 | - | $28.91 M(+189.4%) | $40.55 M(+246.5%) |
| Jun 2022 | - | $9.99 M(+484.4%) | $11.70 M(+507.7%) |
| Mar 2022 | - | $1.71 M(-3518.0%) | $1.93 M(+455.0%) |
| Dec 2021 | $347.00 K | -$50.00 K(-187.7%) | $347.00 K(-23.4%) |
| Sep 2021 | - | $57.00 K(-72.9%) | $453.00 K(-123.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $210.00 K(+61.5%) | -$1.90 M(-100.7%) |
| Mar 2021 | - | $130.00 K(+132.1%) | $255.73 M(-3.7%) |
| Dec 2020 | $265.51 M(+408.8%) | $56.00 K(-102.4%) | $265.51 M(+0.0%) |
| Sep 2020 | - | -$2.30 M(-100.9%) | $265.45 M(-0.9%) |
| Jun 2020 | - | $257.84 M(+2502.6%) | $267.75 M(+2602.6%) |
| Mar 2020 | - | $9.91 M(>+9900.0%) | $9.91 M(-81.0%) |
| Dec 2019 | $52.19 M(+184.1%) | $0.00(0.0%) | $52.19 M(0.0%) |
| Sep 2019 | - | $0.00(0.0%) | $52.19 M(0.0%) |
| Jun 2019 | - | $0.00(-100.0%) | $52.19 M(0.0%) |
| Mar 2019 | - | $52.19 M | $52.19 M |
| Dec 2018 | $18.37 M(-32.4%) | - | - |
| Dec 2017 | $27.17 M | - | - |
FAQ
- What is Fusion Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual CFF year-on-year change?
- What is Fusion Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly CFF year-on-year change?
- What is Fusion Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals TTM CFF year-on-year change?
What is Fusion Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of FUSN is $142.01 M
What is the all time high annual CFF for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual cash flow from financing activities is $265.51 M
What is Fusion Pharmaceuticals annual CFF year-on-year change?
Over the past year, FUSN annual cash flow from financing activities has changed by +$101.27 M (+248.63%)
What is Fusion Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of FUSN is $64.01 M
What is the all time high quarterly CFF for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly cash flow from financing activities is $257.84 M
What is Fusion Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, FUSN quarterly cash flow from financing activities has changed by +$63.68 M (+19415.55%)
What is Fusion Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of FUSN is $146.50 M
What is the all time high TTM CFF for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high TTM cash flow from financing activities is $267.75 M
What is Fusion Pharmaceuticals TTM CFF year-on-year change?
Over the past year, FUSN TTM cash flow from financing activities has changed by +$62.22 M (+73.82%)